Abstract
Esophageal motility disorders are a broad category of diseases with a variety of symptoms, ranging from dysphagia to chest pain. The pathophysiology is not always fully understood, but may involve alterations in inhibitory or excitatory innervation of the smooth muscle of the distal esophagus and LES. High-resolution manometry is the gold standard for its diagnosis, and the Chicago classification offers an organizational framework for better evaluation and management. Major disorders of motility are generally pathologic, and include achalasia, EGJOO, DES, hypertensive esophagus, and diseases of absent peristalsis, such as scleroderma. Treatments are targeted at the particular diagnosis. In achalasia, endoscopic and surgical options are preferred. For the remaining motility diagnoses, medical management forms the mainstay of treatment, which can be limited by side effect profiles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74. https://doi.org/10.1111/nmo.12477.
Richter JE. High-resolution manometry in diagnosis and treatment of achalasia: help or hype. Curr Gastroenterol Rep. 2015;17(1):420. https://doi.org/10.1007/s11894-014-0420-2.
Hoogerwerf WA, Pasricha PJ. Pharmacologic therapy in treating achalasia. Gastrointest Endosc Clin N Am. 2001;11(2):311–24, vii. http://www.ncbi.nlm.nih.gov/pubmed/11319064
Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249(1):45–57. https://doi.org/10.1097/SLA.0b013e31818e43ab.
Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol. 1996;91(9):1724–30. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med4&NEWS=N&AN=8792688
Annese V, Bassotti G, Coccia G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut. 2000;46(5):597–600. https://doi.org/10.1136/gut.46.5.597.
Katzka DA, Castell DO. Review article: an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia. Aliment Pharmacol Ther. 2011;34(8):832–9. https://doi.org/10.1111/j.1365-2036.2011.04816.x.
Richter JE, Vela MF, Richter JE, et al. Update on the management of achalasia: balloons, surgery and drugs. Clin Gastroenterol Hepatol. 2006;4(3):580–7. https://doi.org/10.1586/17474124.2.3.435.
Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103(6):1732–8. https://doi.org/10.1053/j.gastro.2008.07.022.Achalasia.
Chan KC, Wong SKH, Lee DWH, et al. Short-term and long-term results of endoscopic balloon dilation for achalasia: 12 years’ experience. Endoscopy. 2004;36:690–4. https://doi.org/10.1055/s-2004-825659.
Richards WO, Torquati A, Holzman MD, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg. 2004;240(3):405–15. https://doi.org/10.1097/01.sla.0000202000.01069.4d.
Oelschlager BK, Chang L, Pellegrini CA. Improved outcome after extended gastric myotomy for achalasia. Arch Surg. 2003;138(5):490–495-497. https://doi.org/10.1001/archsurg.138.5.490.
Yaghoobi M, Mayrand S, Martel M, Roshan-Afshar I, Bijarchi R, Barkun A. Laparoscopic Heller’s myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta-analysis of randomized, controlled trials. Gastrointest Endosc. 2013;78(3):468–75. https://doi.org/10.1016/j.gie.2013.03.1335.
JCY W. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. J Neurogastroenterol Motil. 2011;17(3):324–6. https://doi.org/10.5056/jnm.2011.17.3.324.
Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65:732–9. https://doi.org/10.1136/gutjnl-2015-310602.
Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71. https://doi.org/10.1055/s-0029-1244080.
Marano L, Pallabazzer G, Solito B, et al. Surgery or peroral esophageal myotomy for achalasia. Medicine (Baltimore). 2016;95(10):e3001. https://doi.org/10.1097/MD.0000000000003001.
Stavropoulos SN, Modayil RJ, Friedel D, Savides T. The international per oral endoscopic myotomy survey (IPOEMS): a snapshot of the global POEM experience. Surg Endosc. 2013;27(9):3322–38. https://doi.org/10.1007/s00464-013-2913-8.
Pérez-Fernández MT, Santander C, Marinero A, Burgos-Santamaría D, Chavarría-Herbozo C. Characterization and follow-up of esophagogastric junction outflow obstruction detected by high resolution manometry. Neurogastroenterol Motil. 2016;28(1):116–26. https://doi.org/10.1111/nmo.12708.
Ishimura N, Mori M, Mikami H, et al. Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers. BMC Gastroenterol. 2015;15(1):1–8. https://doi.org/10.1186/s12876-015-0346-7.
Kusunoki H, Haruma K, Manabe N, et al. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil. 2012;24(6):e250–1. https://doi.org/10.1111/j.1365-2982.2012.01897.x.
Muta K, Ihara E, Fukaura K, Tsuchida O, Ochiai T, Nakamura K. Effects of acotiamide on the esophageal motility function in patients with esophageal motility disorders: a pilot study. Digestion. 2016;94:9–16.
Konturek JW, Gillessen A, Domschke W. Diffuse esophageal spasm: a malfunction that involves nitric oxide? Scand J Gastroenterol. 1995;30(11):1041–5. https://doi.org/10.3109/00365529509101604.
Eherer AJ, Schwetz I, Hammer HF, et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut. 2002;50(6):758–64. https://doi.org/10.1136/gut.50.6.758.
Hershcovici T, Achem SR, Jha LK, Fass R. Systematic review: the treatment of noncardiac chest pain. Aliment Pharmacol Ther. 2012;35(1):5–14. https://doi.org/10.1111/j.1365-2036.2011.04904.x.
Bashashati M, Andrews C, Ghosh S, Storr M. Botulinum toxin in the treatment of diffuse esophageal spasm. Dis Esophagus. 2010;23(7):554–60. https://doi.org/10.1111/j.1442-2050.2010.01065.x.
Vanuytsel T, Bisschops R, Farre R, et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol. 2013;11(9):1115–21.e2. https://doi.org/10.1016/j.cgh.2013.03.021.
Leconte M, Douard R, Gaudric M, Dumontier I, Chaussade S, Dousset B. Functional results after extended myotomy for diffuse oesophageal spasm. Br J Surg. 2007;94(9):1113–8. https://doi.org/10.1002/bjs.5761.
Khan MA, Kumbhari V, Ngamruengphong S, et al. Is POEM the answer for management of spastic esophageal disorders? A systematic review and meta-analysis. Dig Dis Sci. 2017;62(1):35–44. https://doi.org/10.1007/s10620-016-4373-1.
Lund RJ, Wetcher GH, Raiser F, et al. Laparoscopic Toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility. J Gastrointest Surg. 1997;1(4):301–8.
Scheerens C, Tack J, Rommel N. Buspirone, a new drug for the management of patients with ineffective esophageal motility? United European Gastroenterol J. 2015;3(3):261–5. https://doi.org/10.1177/2050640615585688.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Goldin, A., Lo, WK. (2018). Approach to Esophageal Motility Disorders. In: Oleynikov, D., Fisichella, P. (eds) A Mastery Approach to Complex Esophageal Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-75795-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-75795-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75794-0
Online ISBN: 978-3-319-75795-7
eBook Packages: MedicineMedicine (R0)